Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Uy Ear is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/19/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/19/2024 | SAGE | Buy Now | Sage Therapeutics | $12.39 | 29.14% | $18 → $16 | Maintains | Neutral | Get Alert |
| 05/24/2024 | RNAC | Buy Now | Cartesian Therapeutics | $17.70 | 125.99% | → $40 | Initiates | → Buy | Get Alert |
| 05/17/2024 | SRPT | Buy Now | Sarepta Therapeutics | $145.61 | 22.93% | $145 → $179 | Maintains | Buy | Get Alert |
| 05/15/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | 81.82% | $17 → $18 | Maintains | Buy | Get Alert |
| 05/09/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 18.31% | $25 → $21 | Maintains | Neutral | Get Alert |
| 05/08/2024 | QURE | Buy Now | uniQure | $7.74 | -22.48% | $7 → $6 | Maintains | Neutral | Get Alert |
| 04/26/2024 | SAGE | Buy Now | Sage Therapeutics | $12.39 | 45.28% | $20 → $18 | Maintains | Neutral | Get Alert |
| 03/12/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 40.85% | $39 → $25 | Downgrade | Buy → Neutral | Get Alert |
| 03/08/2024 | EOLS | Buy Now | Evolus | $11.96 | 92.31% | $20 → $23 | Maintains | Buy | Get Alert |
| 03/04/2024 | QURE | Buy Now | uniQure | $7.74 | -9.56% | $10 → $7 | Maintains | Neutral | Get Alert |
| 02/28/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | 71.72% | $16 → $17 | Reiterates | Buy → Buy | Get Alert |
| 02/28/2024 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 119.72% | $40 → $39 | Maintains | Buy | Get Alert |
| 02/23/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | 61.62% | $8 → $16 | Reiterates | Buy → Buy | Get Alert |
| 02/14/2024 | SRPT | Buy Now | Sarepta Therapeutics | $145.61 | -0.42% | $130 → $145 | Maintains | Buy | Get Alert |
| 02/08/2024 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -3.91% | $116 → $140 | Maintains | Neutral | Get Alert |
| 01/03/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | -19.19% | $4 → $8 | Upgrade | Neutral → Buy | Get Alert |
| 01/02/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | -19.19% | $4 → $8 | Upgrade | Neutral → Buy | Get Alert |
| 12/29/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 125.35% | $35 → $40 | Maintains | Buy | Get Alert |
| 12/19/2023 | QURE | Buy Now | uniQure | $7.74 | 29.2% | → $10 | Downgrade | Buy → Neutral | Get Alert |
| 12/18/2023 | AVRO | Buy Now | Avrobio | — | — | $60 → $24 | Downgrade | Buy → Neutral | Get Alert |
| 11/22/2023 | RVNC | Buy Now | Revance Therapeutics | $3.63 | 340.17% | $35 → $16 | Maintains | Buy | Get Alert |
| 11/10/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -21.75% | $116 → $114 | Maintains | Neutral | Get Alert |
| 11/06/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 97.18% | $20 → $35 | Upgrade | Neutral → Buy | Get Alert |
| 11/03/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -20.38% | — | Maintains | Neutral | Get Alert |
| 10/27/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | -59.6% | $57 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 10/26/2023 | ALKS | Buy Now | Alkermes | $24.83 | 40.96% | $37 → $35 | Maintains | Buy | Get Alert |
| 09/26/2023 | SRPT | Buy Now | Sarepta Therapeutics | $145.61 | 9.88% | → $160 | Reiterates | Buy → Buy | Get Alert |
| 09/25/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | 475.76% | → $57 | Reiterates | Buy → Buy | Get Alert |
| 09/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -22.44% | → $113 | Reiterates | Neutral → Neutral | Get Alert |
| 08/18/2023 | SELB | Buy Now | Selecta Biosciences | — | — | $4 → $3 | Maintains | Buy | Get Alert |
| 08/02/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -23.12% | $111 → $112 | Maintains | Neutral | Get Alert |
| 06/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 12.68% | → $20 | Reiterates | Neutral → Neutral | Get Alert |
| 06/12/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | 475.76% | → $57 | Reiterates | Buy → Buy | Get Alert |
| 06/07/2023 | EOLS | Buy Now | Evolus | $11.96 | 67.22% | $17 → $20 | Maintains | Buy | Get Alert |
| 06/07/2023 | JNJ | Buy Now | Johnson & Johnson | $154.41 | -74.09% | $36 → $40 | Maintains | Buy | Get Alert |
| 05/10/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | 475.76% | $61 → $57 | Maintains | Buy | Get Alert |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -23.81% | $116 → $111 | Maintains | Neutral | Get Alert |
| 04/27/2023 | ALKS | Buy Now | Alkermes | $24.83 | 44.99% | $37 → $36 | Maintains | Buy | Get Alert |
| 04/14/2023 | SRPT | Buy Now | Sarepta Therapeutics | $145.61 | 9.88% | → $160 | Reiterates | → Buy | Get Alert |
| 04/14/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 12.68% | → $20 | Reiterates | → Neutral | Get Alert |
| 04/14/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -20.38% | → $116 | Reiterates | → Neutral | Get Alert |
| 04/11/2023 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | 516.16% | → $61 | Reiterates | → Buy | Get Alert |
| 04/11/2023 | ALKS | Buy Now | Alkermes | $24.83 | 49.01% | $36 → $37 | Maintains | Buy | Get Alert |
| 03/30/2023 | STSA | Buy Now | Satsuma Pharma | — | — | → $2 | Reiterates | → Neutral | Get Alert |
| 03/24/2023 | AVRO | Buy Now | Avrobio | — | — | $72 → $60 | Maintains | Buy | Get Alert |
| 03/22/2023 | SELB | Buy Now | Selecta Biosciences | — | — | $5 → $4 | Maintains | Buy | Get Alert |
| 03/17/2023 | CABA | Buy Now | Cabaletta Bio | $7.09 | 41.04% | → $10 | Reiterates | → Buy | Get Alert |
| 03/17/2023 | SRPT | Buy Now | Sarepta Therapeutics | $145.61 | 9.88% | → $160 | Reiterates | → Buy | Get Alert |
| 03/13/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 7.04% | → $19 | Reiterates | → Neutral | Get Alert |
| 03/01/2023 | OCGN | Buy Now | Ocugen | $1.65 | 81.79% | $5 → $3 | Maintains | Buy | Get Alert |
| 02/28/2023 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | 7.04% | $15 → $19 | Maintains | Neutral | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -20.38% | → $116 | Maintains | Neutral | Get Alert |
| 01/19/2023 | EOLS | Buy Now | Evolus | $11.96 | 42.14% | $15 → $17 | Maintains | Buy | Get Alert |
| 12/21/2022 | ACAD | Buy Now | ACADIA Pharmaceuticals | $17.75 | -15.49% | $17 → $15 | Maintains | Neutral | Get Alert |
| 11/22/2022 | ALKS | Buy Now | Alkermes | $24.83 | 44.99% | $34 → $36 | Maintains | Buy | Get Alert |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -20.38% | $105 → $116 | Maintains | Neutral | Get Alert |
| 10/20/2022 | NBIX | Buy Now | Neurocrine Biosciences | $145.69 | -27.93% | $98 → $105 | Maintains | Neutral | Get Alert |
| 08/23/2022 | OCGN | Buy Now | Ocugen | $1.65 | 202.98% | → $5 | Initiates | → Buy | Get Alert |
| 04/07/2022 | ARQT | Buy Now | Arcutis Biotherapeutics | $9.90 | 475.76% | $58 → $57 | Maintains | Buy | Get Alert |
| 01/06/2022 | AVRO | Buy Now | Avrobio | — | — | $336 → $72 | Maintains | Buy | Get Alert |
| 06/27/2019 | AVRO | Buy Now | Avrobio | — | — | → $336 | Initiates | → Buy | Get Alert |
